The pharmacogenetics of antidepressant treatments for depressive disorders

Drug Development Research

Volumn 65, Issue 3, 2005, Pages 170-178

  Lee, Min Soo ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Depression; Norepinephrine transporter; Pharmacogenetics; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; ERGOLINE DERIVATIVE; FLUOXETINE; FLUVOXAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; NORADRENALIN; NORADRENALIN TRANSPORTER; NORADRENALIN TRANSPORTER INHIBITOR; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SEROTONIN 2A RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTAMINE; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; VENLAFAXINE;

ALLELE; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; GENE EXPRESSION; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHARMACOGENETICS; POINT MUTATION; PROTEIN FUNCTION; REVIEW;

EID: 28444436223     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.20020     Document Type: Review

References (84)

1. Amara SG, Kuhar MJ. 1993. Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
2. Arora RC, Meltzer HY. 1989. Serotonergic measures in the brains of suicide victims: S-HT(2) binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146:730-736.
3. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R. 1995. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346:281-282.
4. Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW. 1998. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 3:61-66, 1145-1150.
5. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ. 1998. Gprotein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 32:1094-1097.
6. Bondy B, Baghai TC, Zill P, Bottlender R, Jaeger M, Minov C, Schule C, Zwanzger P, Rupprecht R, Engel RR. 2002. Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to Cardiovascular disease? Mol Psychiatry 7:1120-1126.
7. Bonisch H, Bruss M. 1994. The noradrenaline transporter of die neuronal plasma membrane. Ann NY Acad Sci 733:193-202.
8. Boularand S, Darmon MC, Ganem Y, Launay JM, Mallet J. 1990. Complete coding sequence of human tryptophan hydroxylase. Nucleic Acids Res 18:4257.
9. Brain Res 618:308-312.
10. Burnet PW, Eastwood SL, Lacey K, Harrison PJ. 1995. The distribution of 5-HT1A and 5-HT2A receptor mRNA in human barin. Brain Res 675:157-168.
11. Chang HW, Yen CY, Liu SY, Singer G, Shih IeM. 2002. Genotype analysis using human hair shaft. Cancer Epidemiol Biomarkers Prev 11:925-929.
12. Chen K, Yang W, Grimsby J, Shih JC. 1992. The human 5HT2A receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res 14:20-26.
13. Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS. 2005. Serotonin receptor 2A gene polymorphsim(-1438A/G) and short-term treatment response to citalopram. Neuropsychobiology 52:155-162.
14. Craig SP, Boularand S, Darmon MC, Mallet J, Craig IW. 1991. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenet Cell Genet 56:157-159.
15. Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, Lorenzi C, Smeraldi E. 2002. Influence of monoamine oxydase A and serotonin receptor 2A polymorphisms in SSRIs antidepressants activity. Int J Neuropsychopharmacol 5:27-35.
16. DeBellis M, Geracioti T, Altemus M. 1993. Cerebrospinal fluid monoamine metabolites in fluoxetine treated patients with major depression and in healthy volunteers. Biol Psychiatry 33:636-641.
17. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. 1999. Association between the C825T polymorphism of die G protein beta3- subunit gene and hypertension in blacks. Hypertension 34:1193-1196.
18. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Human Genet 97:614-619.
19. Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, Rosal R, Weng G, Yang CS, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ, Hamm HE. 1998. Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280:1271-1274.
20. Glennon RA, Dukat M. 1995. Serotonin receptor subtypes. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress, vol. 45. New York: Raven Press, p 1125-1131.
21. Hamm HE. 1998. The many faces of G protein signaling. J Biol Chem 273:669-672.
22. Hegele RA, Anderson C, Young TK, Connelly PW. 1999. G-protein betaS subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 9:972-977.
23. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. 1996. Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
24. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW, Fischer M, Riegger GA, Holmer SR. 2001. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 49:820-827.
25. Jeffrey H Meyer, Shitij Kapur, Beata Eisfeld, Gregory M Brown. 2001. The effect of paroxetine on 5-HT(2A) receptors in depression: An [18F]setoperone PET imaging study. Am J Psychiatry 158:78-86.
26. Kim CH, Kim HS, Cubells JF, Kim KS. 1999. A previously undescribed intron and extensive 5'upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem 274:6507-6518.
27. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, Carroll BJ. 2000. Serotonin transporter gene polymorphism and antidepressants response. Neuroreport 11:215-219.
28. Kim JW. 2003. Association study and the population admixture. In: Korean Society of Biological Psychiatry: Human Neurobehavioral Genetics in the 21st Century. Winter Workshop, 7 November 2003, Seoul.
29. Kohen R, Fashingbauer LA, Heidman DE, Guthrie CR, Hamblin MW. 1996. Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem 66:47-56.
30. Kunugi H, Kato T, Fukuda R, Tatsumi M, Sakai T, Nanko S. 2002. Association study of C825T polymorphism of the G-protein beta3 subunit gene with schizophrenia and mood disorders. J Neural Transm 109:213-218.
31. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. 1982. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 139:1315-1318.
32. Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH. 2002. Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 159:1593-1595.
33. Lee HJ, Cha JH, Ham BJ, Han CS, Kim YK, Lee SH, Ryu SH, Kang RH, Choi MJ, Lee MS. 2004. Association between a G-protein b3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenom J 4:29-33.
34. Lee MS, Lee HY, Lee HJ, Ryu SH. 2004. Serotonin transporter promoter gene polymorphism and long-term outcome of anti-depressants treatment. Psychiatric Genet 14:111-115.
35. Lee SH, Lee KJ, Lee HJ, Ham BJ, Ryu SH, Lee MS. 2005. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressants treatment in major depressive disorder. Psychiatry and Clinical Neurosciences 59:140-145.
36. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P. 1994. Organization of the human serotonin transporter gene. J Neural Transm. Gen Sect 95:157-162.
37. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
38. Lin CN, Tsai SJ, Hong CJ. 2001. Association analysis of a functional G protein beta3 subunit Gene polymorphism (C825T) in mood disorders. Neuropsychobiology 44:118-121.
39. Maj J, Bijak M, Dziedzicka-Wasylewska M, Rogoz R, Rogoz Z, Skuza G, Okarsld T. 1996. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) 127:73-82.
40. Massana J. 1998. Reboxetine versus fluoxetine: An overview of efficacy and tolerability. J Cli Psychiatry 59(Suppl 14):8-10.
41. Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B. 2001. Serotonin-2A-receptor and - transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303:119-122.
42. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. 1993. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol 43:320-327.
43. Montgomery SA. 1994. Long-term treatment of depression. Br J Psychiatry 26(Suppl):31-36.
44. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D. 1997. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45:145-148.
45. Owens MJ. 1997. Molecular and cellular mechanisms of antidepressants drugs. Depress Anxiety 4:153-159.
46. Pickar D, Rubinow K. 2001. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci 22:75-83.
47. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ. 2000. Allelic variation in the serotonin transporter promoter affects onset of paroxetiue treatment response in late-life depression. Neuropsychopharmacology 23:587-590.
48. Porzgen P, Bonisch H, Bruss M. 1995. Molecular cloning and organization of the coding regio of the human norepinephrine transporter gene. Psychiatry 26:1279-1283.
49. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD. 1993. Antidepressants- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
50. Rausch JL, Johnson ME, Fei YJ, Li JQ, Shendarkar N, Hobby HM, Ganapathy V, Leibach FH. 2002. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 51:723-732.
51. Rosskopf D, Koch K, Habich C, Geerdes J, Ludwig A, Wilhelms S, Jacobs KH, Siffert W. 2003a. Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal 15:479-488.
52. Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C, Urban M, Kohnen S, Graf E, Ravens U, Siffert W. 2003b. Identification and characterization of Gbeta3s2, a novel splice variant of the G-protein beta3 subunit. Biochem J 371:223-232.
53. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR. 1994. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine- 6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther 268:1403-1410.
54. Roy A, Pickar D, Dejong J, Karoum F, Linnoila M: Norepinephrine and its metabolites I cerebrospinal fluid, plasma and urine. 1998. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch Gen Psychiatry 45:849-857.
55. Sato K, Yoshida K, Takahashi H, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K. 2002. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. Neuropsychobiology 46:136-140.
56. Scates AC, Doraiswamy PM. 2000. Reboxetine: A selective norepmephrine reuptake inhibitor for the treatment of depression. Ann Pharmacother 34:1302-1312.
57. Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E. 2003. SSRIs Antidepressants activity is influenced by Gbeta3 variants. Eur Neuropsychopharmacol 13:117-122.
58. Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E. 2001a. Tryptophan hydroxylase gene associated with paroxetine antidepressants activity. Eur Neuropsychopharmacol 11:375-380.
59. Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E. 2001b. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressants activity. Mol Psychiatry 6:586-592.
60. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Erlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tülikainen A, Ge J, Wang Y, Rosskopf D. 1999. Worldwide Ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 10:1921-1930.
61. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. 1998. Association of a human G protein beta3 subunit variant with hypertension. Nat Genet 18:45-48.
62. Siffert W. 2003. G-protein beta3 subunit 825T allele and hypertension. Curr Hypertens Rep 5:47-53.
63. Skrebuhhova T, Allikmets L, Matto V. 1999. 5-HT2A receptors mediate the effects of antidepressantss in the elevated plus-maze test but have a partial role in the forced swim test. Med Sci Res 27:277-280.
64. Sleight AJ, Boess FG, Bos M, Bourson A. 1998. The putative 5-ht6 receptor: Localization and function. Ann. N.Y. Acad. Sci 861:91-96.
65. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. 1998. Polymorphism Within the promoter of the serotonin transporter gene and antidepressants efficacy of fluvoxamine. Mol Psychiatry 3:508-511.
66. Smeraldi E, Benedetti F, Zanardi R. 2002. Serotonin transporter promoter genotype and illness recurrence in mood disorders. Eur Neuropsychopharmacol 12:73-75.
67. Spurlock G, Helis A, Holmas P, Williams J, Dsouza UM, Cardno A. 1998. A family based Association study of T 102C polymorphism in 5HT2A and schizophrenia plus identification of New polymorphisms in the promoter. Mol psychiatry 3:42-49.
68. Szot P, Ashliegh EA, Kohen R, Petrie E, Dorsa DM, Veith R. 1993. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res 618:308-312.
69. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg HM, Ashleig EA, Castillo S, Peskind ER, Pascualy M, Halter JB. 1994. Sympathetic nervous system activity in major depression. Arch Gen Psychiatry 51:411-422.
70. Virchow S, Ansorge N, Rosskopf D, Rubben H, Siffert W. 1999. The G protein beta3 subunit Splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn-Schmiedebergs Arch Pharmacol 360:27-32.
71. Vogt IR, Shimron-Abarbanell D, Neidt H, Erdmann J, Cichon S, Schulze TG, Muller DJ, Maier W, Albus M, Borrmann-Hassenbach M, Knapp M, Rietschel M, Propping P, Nothen MM. 2000. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am J Med Genet 96:217-221.
72. Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibley DR, Dorsa DM. 1995. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64:1105-1111.
73. Wu WH, Huo SJ, Cheng CY, Hong CJ, Tsai SJ. 2001. Association study of the 5-HT (6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders. Neuropsychobiology 44:172-175.
74. Yates M, Leake A, Candy JM, Fairbairm AF, McKeith IG, Ferner IN. 1990. 5HT2 receptor changes in major depression. Biol Psychiatry 27:489-496.
75. Yatham LN, Liddle PF, Dennie J. 1999. Decrease in brain serotonin2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labled setoperone. Arch Gen Psychiatry 56:705-711.
76. Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K. 2002. Influence of the Serotonin transporter gene-linked polymorphic region on the antidepressants response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 26:383-386.
77. Yoshida K, Naito S, Takahashi H, Sato K, Ito K, Kamata M, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K. 2002. Monoamine oxidase: a gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressants response to fluvoxamine in Japanese patients with major depressive disorder. Pro Neuropsychopharmacol Biol Psychiat 26:1279-1283.
78. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, Naito S, Shimizu T, Itoh K, Inoue K, Suzuki T, Nemeroff CB. 2004. Prediction of antidepressants response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 161:1575-1580.
79. Yoshioka M, Matsumoto M, Togashi H, Mori K. 1998. Central distribution and function of 5-ht6 receptor subtype in the rat brain. Ann NY Acad Sci 861:244.
80. Yu YWY, Tsai SJ, Chen TJ, Lin CH, Hong CJ. 2002. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressants response in major depressive disorders. Mol Psychiatry 7:1115-1119.
81. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E. 2000. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 20:105-107.
82. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, Dotoli D, Smeraldi E. 2001. Factors affecting fluvoxamine antidepressants activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 50:323-330.
83. Zill P, Baghai TC, Zwanzger P Schule C, Minov C, Riedel M, Neumeier K, Rupprecht R, Bondy B. 2000. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressants treatment. Neuroreport 11:1893-1897.
84. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, Zwanzger P, Schule C Minov C, Behrens S, Rupprecht R, Hegerl U, Moller HJ, Bondy B. 2002. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression.